Celldex Therapeutics, Inc. - Director's Dealing 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2010-09-10

Reporting Person: Marucci Anthony S (President & CEO)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-09-10	Common Stock	P	2500	$3.43	Acquired	2500	Direct
2010-09-10	Common Stock	P	200	$3.409	Acquired	200	Direct
2010-09-10	Common Stock	P	2300	$3.410	Acquired	2300	Direct
2010-09-10	Common Stock	P	300	$3.4579	Acquired	300	Direct
2010-09-10	Common Stock	P	500	$3.46	Acquired	500	Direct
2010-09-10	Common Stock	P	200	$3.4598	Acquired	200	Direct
2010-09-10	Common Stock	P	200	$3.47	Acquired	200	Direct
2010-09-10	Common Stock	P	1600	$3.48	Acquired	1600	Direct
2010-09-10	Common Stock	P	100	$3.4791	Acquired	100	Direct
2010-09-10	Common Stock	P	400	$3.4792	Acquired	400	Direct
2010-09-10	Common Stock	P	100	$3.4794	Acquired	100	Direct
2010-09-10	Common Stock	P	200	$3.4798	Acquired	200	Direct
2010-09-10	Common Stock	P	1500	$3.479	Acquired	1500	Direct
2010-09-10	Common Stock	P	181	$3.4575	Acquired	181	Direct
2010-09-10	Common Stock	P	1400	$3.459	Acquired	1400	Direct
2010-09-10	Common Stock	P	319	$3.4589	Acquired	319	Direct